406 filings
Page 4 of 21
8-K
y46a7zt at5i9n
17 Sep 10
Alkermes Announces FDA Advisory Committee Recommends Approval of VIVITROL(R) for Opioid Dependence
12:00am
8-K
uqeo ygym
5 Aug 10
Alkermes Reports First Quarter Fiscal 2011 Financial Results
12:00am
8-K
7malo e3chiq
22 Jul 10
Departure of Directors or Certain Officers
12:00am
CT ORDER
3m3hv
28 Jun 10
Confidential treatment order
12:00am
8-K
0t9pk
13 May 10
Alkermes Reports Financial Results for Fiscal 2010 and Provides Financial Expectations for Fiscal 2011
12:00am
8-K
gz6wckytz7riu
6 May 10
Regulation FD Disclosure
12:00am
8-K
rc6uc
19 Apr 10
Regulation FD Disclosure
12:00am
8-K
lrazkmipqufm28gn24z
25 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
1a3 r5ihbeqt8nyb
15 Mar 10
Amylin, Lilly and Alkermes Receive Complete Response Letter from Fda for Exenatide Once Weekly Submission
12:00am
8-K
kafdv6yt
4 Feb 10
Results of Operations and Financial Condition
12:00am
8-K
p6kri 9bp
3 Dec 09
Other Events
12:00am
8-K
sfn5pma5r
5 Nov 09
Results of Operations and Financial Condition
12:00am
8-K
l2z06
11 Sep 09
Departure of Directors or Certain Officers
12:00am
8-K
q7i78hgf 83itfk
26 Aug 09
Regulation FD Disclosure
12:00am